reason report
ceo cfo convo upsid t/a still track contract
bottom line reiter op lower pt
post report guidanc convers ceo
zubretski cfo white preliminari guidanc
look conserv upsid consensu base
mlr like improv beyond flat yoy guidanc exchang
margin around rather break-even guidanc medic cost
trend flu guid conserv model base case
ep bull case contempl net margin
pre tax reform post tax reform net margin
guidanc rang workforc reduct contribut
mm pre tax incom expect get increment
save mm progress margin
pois occur view model averag margin
ep estim run rate margin
ep tax tailwind unlik expand margin
sustain beyond near term obviou rate claw
back state date per ceo zubretski clearli loss
fl nm contract good news though unprofit
protest offer upsid estim tx contract award oct
wa contract re-procur import catalyst though
full effort new organ behind rfp process pam
sedmak former medicaid ceo aet mark keim join
lead oper organiz restructur turnaround
effort balanc sheet continu improv debt capit
parent cash mm see sell strong buy
opportun pt contempl pe
ep report may may day next catalyst
decent one timer exchang headwind debt pay
restructur charg contribut lion share
miss medicaid medicar improv bp qoq
day claim payabl measur reserv strength day
initi guidanc conserv room meaning
upsid base case ep midpoint
adjust ep guidanc consensu preliminari
guidanc look conserv upsid consensu
base mlr like improv beyond flat yoy
guidanc exchang margin around rather break-even
guidanc medic cost trend flu guid conserv
model base case ep bull case
contempl net margin pre tax reform post tax reform net
margin guidanc workforc reduct
contribut mm pre tax incom expect get
increment save mm
normal ep
net debt total capit
price-to-earnings lt ep growth
estimate lt ep growth compound-annual-growth-rate
compani inform leerink partner llc research
number may add due roud
revenu billion ep estim ep quarterli number may sum total round
pleas refer page analyst certif import disclosur price chart disclosur specif
cover compani statement valuat risk avail
progress margin pois occur
view model averag margin ep
estim run rate margin ep
downsid risk contract loss price recent sell-off
clearli loss fl nm contract good news though
unprofit protest offer upsid estim tx contract
award oct wa contract re-procur import
catalyst though full effort new organ behind
rfp process pam sedmak former medicaid ceo aet mark
keim join lead oper organiz restructur
turnaround effort
balanc sheet continu improv debt capit
parent cash mm
see sell strong buy opportun pt
contempl pe ep report may
may day next catalyst
reiter op lower pt post report
guidanc convers ceo zubretski cfo white preliminari
guidanc look conserv upsid consensu base mlr
like improv beyond flat yoy guidanc exchang margin around rather
break-even guidanc medic cost trend flu guid conserv model
base case ep bull case contempl net margin pre tax
reform post-tax reform net margin guidanc rang
workforc reduct contribut mm pre-tax incom expect get
increment save mm progress margin pois
occur view model averag margin ep
estim run rate margin ep tax tailwind unlik
expand margin sustain beyond near term obviou rate claw back
state date per ceo zubretski clearli loss fl nm contract good news
though unprofit protest offer upsid estim tx contract award oct
wa contract re-procur import catalyst though full effort
new organ behind rfp process pam sedmak former medicaid ceo aet
mark keim join lead oper organiz restructur turnaround
effort balanc sheet continu improv debt capit parent cash
mm see sell strong buy opportun pt contempl pe
ep report may may day next catalyst
decent one timer exchang headwind debt pay restructur
charg contribut lion share miss medicaid medicar improv
bp qoq day claim payabl measur reserv strength day
decent miss driven larg one timer
consolid miss estim improv bp qoq estim
bp
earningsreport estimatesstreetaccount estimatesreport sequentialreport yoytot oper earn interest estimatesstreetaccount estimatesreport sequentialreport yoykey metricsconsolid bpsservic revenu bpsg total bpstax bpsday claim inc
day claim payabl increas yoy sequenti
claim payabl inc
overal membership decreas sequenti driven decreas hix membership
under-perform driven mainli one-tim
initi guidanc conserv room meaning upsid base case
ep midpoint adjust ep guidanc consensu
preliminari guidanc look conserv upsid consensu
base mlr like improv beyond flat yoy guidanc exchang margin
around rather break-even guidanc medic cost trend flu guid
conserv model base case ep bull case
contempl net margin pre-tax reform post-tax reform net margin
guidanc workforc reduct contribut mm pre-tax incom
expect get increment save mm
report pre-tax break-up risk incom exclud exclud baselin ep ex- one ep exclud one-tim inc
ep guidanc conserv view leav room upsid
manag commentari also allud conservat
parametercompani guidanc estimatesconsensu estimatespremium revenu fee reimburs tax revenu revenu incom revenu cost cost expens tax expens insur fee amort interest expens tax tax incom net incom share outstand guidanc provid appropri amount execut risk preliminari guidanc therefor develop appropri conserv view medic cost baselin medic cost trend potenti rate increas retain amount revenu risk turnaround marketplac busi observ achiev margin implicit price joseph zubretski presid ceo director inc call inc
estim base ep bull continu improv
exchang margin
progress margin pois occur view model
averag margin ep estim run rate margin
ep
baselin ep ex one busi bp improv medicaid busi current flat guidanc premium revenueexchang margin pre-tax margin premium revenu mm guid savingstax reform tailwind tax reformrevenu premium revenu adjust pre-tax margin cost wage start-up mm addit comp start-up costsleeink base margin improv exchang bp addit margin improv exchang busi total pre-tax margin improv busi medicaid medicar improv addit bp total improv bp current flat guidanceleerink bull scenario inc
model ep averag net margin
downsid risk contract loss price recent sell-off clearli loss fl
nm contract good news though unprofit protest offer upsid
estim tx contract award oct wa contract re-procur import
catalyst though full effort new organ behind rfp process pam
sedmak former medicaid ceo aet mark keim join lead oper
organiz restructur turnaround effort
loss fl nm contract news
downsid risk price sell
manag focus retain upcom tx wa contract
balanc sheet continu improv debt capit parent cash
texa respons texa abd propos in-flight due submit earli march told award announc late octob region texa right statewid propos obvious first focu retain actual room grow servic profil deep provid relationship skill nurs facil network realli good servic platform possibl actual grow rfp would remind rate part either one propos capabl servic profil rate negoti later phenomenon new player come tri sort invest state exist either one washington market share great platform integr behavior medic track record two nine region alreadi two nine region washington actual went procur past two year actual grew membership re-procur cost base washington run value-bas contract believ best market feel pretti good market share perspect abil grow servic profil track record either state joseph zubretski presid ceo director inc call inc
end year debt cap
continu oper turnaround help unlev balanc sheet
capitaland reason pop leverag actual reduct equiti due charg took joseph zubretski presid ceo director inc call think best way express view leverag realli light expect abl make better inform decis see profit improv driven everyth talk today manifest earn basic go go manag cash leverag appropri go bring much disciplin go focus manag far major decis go forward go first see much grow way lower debt-tocap ratio retain earn joseph white cfo inc call inc
see sell strong buy opportun pt contempl pe
ep report may may day next catalyst
trade ep
except per oper tax contract oper incom continu net incom net ep ex-on growth inc
primari valuat methodolog base rel price-to-earnings rel price-to-earnings
track function compani histori manag group averag assess
potenti price-to-earnings expans next month base forward forecast
contempl underli fundament implic healthcar reform dcf valuat
leverag forward forecast wacc termin growth rate inform
potenti multipl expans along sector compani specif catalyst expect
greater potenti multipl expans dcf valuat point significantli upsid
peer current trade level
free cash flow yield ratio also inform potenti multipl expans
except low ratio and/or high free cash flow yield point potenti greater
multipl expans use absolut rel price-to-earnings multipl base approach valuat
ep estim combin price-to-earnings base approach dcf model point
intrins valu compani plu add premium deal probabl
price target repres price-to-earnings ep pt reflect
higher probabl aet-cv deal closur
downsid risk invest thesi valuat aet legisl regulatori
polici chang could either dis-intermedi health insur us benefit
marketplac place unforeseen top-lin margin headwind commerci medicar
advantag medicaid dual elig book busi not-for-profit health insur
price irrat commerci health benefit marketplac acceler employ exit
sponsorship health benefit us marketplac post implement
afford act advers select public exchang protect adequ
given delay true-up govern payment acquisit asset
without attract return capit investor organiz and/or oper risk
lead execut mis-step downsid risk earn
upsid risk invest thesi valuat aet accret acquisit
use debt rais deal success appeal court decis
primari valuat methodolog base rel price-to-earnings rel price-to-earnings
track function compani histori manag group averag assess
potenti price-to-earnings expans next month base forward forecast
contempl underli fundament implic healthcar reform
dcf valuat leverag forward forecast wacc termin growth rate
inform potenti multipl expans along sector compani specif catalyst
expect greater potenti multipl expans dcf valuat point significantli
upsid peer current trade level free cash flow yield ratio also inform
potenti multipl expans except low ratio and/or high free cash flow yield
point potenti greater multipl expans
new pt contempl price-to-earnings ep
risk invest thesi valuat
legisl regulatori polici chang could either dis-intermedi
insur us benefit marketplac place unforeseen top-lin margin
headwind commerci medicar advantag medicaid dual elig book
not-for-profit health insur price irrat commerci health benefit
acceler employ exit sponsorship health benefit us
marketplac post implement afford act
advers select public exchang protect adequ given delay
true-up govern payment
acquisit asset without attract return capit investor
organiz and/or oper risk drive execut mis-step downsid risk
earn
primari valuat methodolog base rel price-to-earnings rel price-to-earnings
track function compani histori manag group averag assess
potenti price-to-earnings expans next month base forward forecast
contempl underli fundament implic healthcar reform dcf valuat
leverag forward forecast wacc termin growth rate inform
potenti multipl expans along sector compani specif catalyst expect
greater potenti multipl expans dcf valuat point significantli upsid
peer current trade level free cash flow yield ratio also inform
potenti multipl expans except low ratio and/or high free cash flow yield
point potenti greater multipl expans
base price-to-earnings multipl appli ep rate ci outperform
price target
non-profit bcb plan insur price irrat commerci market
medic cost trend come higher anticip potenti econom downturn
provid re-up intens servic deliveri cobra acceler uptak
member util care advanc layoff pandem
employ exit rapidli sponsorship health benefit combat medic
cost inflat catalyz econom downturn
risk declin invest yield invest impair
state-bas actuari rate review limit sound price underwrit caus
longer term state-bas insur exchang advers select reduc
sustain earn power employ dump employe health insur
exchang signific margin compress potenti downsid membership
top line also present long-term risk
polit shock lead singl payer
compani specif risk signific declin equiti market could result increas
fund compani pension oblig polit legal oper regulatori
econom risk foreign oper
dcf valuat leverag forward forecast wacc termin growth rate
inform potenti multipl expans along sector compani specif catalyst
expect greater potenti multipl expans dcf valuat point significantli
upsid peer current trade level free cash flow yield ratio also inform
potenti multipl expans except low ratio and/or high free cash flow yield
point potenti greater multipl expans price base case
ep estim
risk valuat includ
start-up cost underwrit issu associ new busi on-board
particularli challeng new popul dual elig
annual off-cycl rate chang state medicaid program
uncertainti associ competit bid process state
legisl regulatori judici polici chang medicaid entitl program
state feder suprem court level also risk consid
remain posit reiter op rate month pt
contempl price-to-earnings ep
risk invest thesi valuat legisl regulatori
polici chang could either dis-intermedi health insur us benefit
marketplac place unforeseen top-lin margin headwind commerci medicar
advantag medicaid dual elig book busi not-for-profit health insur
price irrat commerci health benefit marketplac acceler employ exit
sponsorship health benefit us marketplac post implement
afford act advers select public exchang protect adequ
given delay true-up govern payment acquisit asset
without attract return capit investor organiz and/or oper risk
lead execut mis-step downsid risk earn acceler medic cost trend
util improv economi
pt reflect price-to-earnings ep
start-up cost underwrit issu associ new busi on-board
particularli challeng new popul dual elig
annual off-cycl rate chang state medicaid program
uncertainti associ competit bid process state
legisl regulatori judici polici chang medicaid
scale issu result loss specialti rx pharmaci contract
acquisit offer adequ return capit
upsid takeout substanti premium key risk
carve-out behavior health servic current state contract
primari valuat methodolog base rel price-to-earnings rel price-to-earnings
track function compani histori manag group averag assess
potenti price-to-earnings expans next month base forward forecast
contempl underli fundament implic healthcar reform
primari valuat methodolog base rel price-to-earnings rel price-to-earnings
track function compani histori manag group averag assess
potenti price-to-earnings expans next month base forward forecast
contempl underli fundament implic healthcar reform
dcf valuat leverag forward forecast wacc termin growth rate
inform potenti multipl expans along sector compani specif catalyst
expect greater potenti multipl expans dcf valuat point significantli
upsid peer current trade level
free cash flow yield ratio also inform potenti multipl expans
except low ratio and/or high free cash flow yield point potenti greater
base post month turnaround rate outperform pt
contempl price-to-earnings ep
risk highlight first spike util on-board new state contract
dual elig integr second state-bas insur exchang result advers
select reduc sustain earn power third state-bas contract rate increas
suffici cover medic trend off-set industri fee medicaid premium fourth risk re-
procur exist contract could creat substanti downsid risk volatil fifth
legisl judici risk manag medicaid entitl extrem case singl
payer model also possibl downsid
primari valuat methodolog base rel price-to-earnings rel price-to-earnings
track function compani histori manag group averag assess
potenti price-to-earnings expans next month base forward forecast
contempl underli fundament implic healthcar reform
dcf valuat leverag forward forecast wacc termin growth rate
inform potenti multipl expans along sector compani specif catalyst
expect greater potenti multipl expans dcf valuat point significantli
upsid peer current trade level
free cash flow yield ratio also inform potenti multipl expans
except low ratio and/or high free cash flow yield point potenti greater
rate outperform price target contempl price-to-earnings
cash ep
non-profit bcb plan insur price irrat commerci market rapidli
medic cost trend come higher anticip potenti double-dip recess
provid re-up intens servic deliveri cobra acceler uptak member util
care advanc lay-off pandem
employ exit rapidli sponsorship health benefit combat medic cost
inflat catalyz double-dip recess
risk declin invest yield invest impair
state-bas actuari rate review limit sound price underwrit caus substanti
long-term state base health insur exchang advers select reduc
sustain earn power employ dump employe health insur
exchang signific margin compress also potenti downsid membership
risk relat collect industri fee medicar medicaid premium
polit shock lead singl payer
compani specif risk downsid risk price target includ acquisit asset
arena yield adequ return capit
primari valuat methodolog base rel price-to-earnings rel price-to-earnings
track function compani histori manag group averag assess
potenti price-to-earnings expans next month base forward forecast
contempl underli fundament implic healthcar reform
dcf valuat leverag forward forecast wacc termin growth rate
inform potenti multipl expans along sector compani specif catalyst
expect greater potenti multipl expans dcf valuat point significantli
upsid peer current trade level
free yield ratio also inform potenti multipl expans
except low ratio and/or high free yield point potenti greater
base rate wcg outperform pt contempl price-to-earnings
ep
downsid risk price target includ execut new state contract dual elig
award rate increas suffici cover medic trend state clawback tax off-set tax
reform tailwind potenti dial medicaid expans ky upsid risk price
target includ take-out larger player
